# Time to CD20 B-Cell Return After Rituximab in Patients with Antineutrophil Cytoplasmic Antibody Vasculitis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/time-to-cd20-b-cell-return-after-rituximab-in-patients-with-antineutrophil/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Noah Huizenga,Karen Laliberte,Reza Zonozi,Jillian Rosenthal,Anushya Jeyabalan,Frank B. Cortazar,John Niles |
| Citations | 1 |
| DOI | 10.1681/asn.20203110s1542e |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4396999152 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Jillian Rosenthal](https://scholariq.org/researchers/jillian-rosenthal/)

## Paper journal

- [Journal of the American Society of Nephrology](https://scholariq.org/journals/journal-of-the-american-society-of-nephrology/)

## Paper primary topic

- [Coagulation, Bradykinin, Polyphosphates, and Angioedema](https://scholariq.org/topics/coagulation-bradykinin-polyphosphates-and-angioedema/)

## Paper topics

- [Coagulation, Bradykinin, Polyphosphates, and Angioedema](https://scholariq.org/topics/coagulation-bradykinin-polyphosphates-and-angioedema/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Platelet Disorders and Treatments](https://scholariq.org/topics/platelet-disorders-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.